News Edwards Lifesciences Corporation Xetra

Equities

EWL

US28176E1082

Real-time Estimate Tradegate Other stock markets 10:41:07 2024-05-17 am EDT			5-day change	1st Jan Change
81.82 ^EUR	-1.49%		+1.66%	+19.19%

May. 14	Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	MT
May. 13	Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences : First Quarter 2024 Fact Sheet	May. 15	PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	May. 14	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	May. 13	MT
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	May. 13	MT
Edwards Lifesciences hit with Meril's EU antitrust complaint	May. 13	RE
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	May. 08	BU
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	May. 08	CI
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	May. 07	MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	May. 01	MT
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	Apr. 30	MT
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72	Apr. 29	MT
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92	Apr. 26	MT
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83	Apr. 26	MT
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $99 From $94	Apr. 26	MT
UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating	Apr. 26	MT
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85	Apr. 26	MT
Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86	Apr. 26	MT
Well, it isn't as bad as feared...	Apr. 26
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
Transcript : Edwards Lifesciences Corporation, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am EDT